Literature DB >> 30010668

Rapid, Safe, and Simple Manual Bedside Nucleic Acid Extraction for the Detection of Virus in Whole Blood Samples.

Maiken W Rosenstierne1, Christopher E Jensen2, Anders Fomsgaard3.   

Abstract

The rapid diagnosis of an infection is essential for the outbreak management, risk containment, and patient care. We have previously shown a method for the rapid bedside inactivation of the Ebola virus during blood sampling for safe nucleic acid (NA) tests by adding a commercial lysis/binding buffer directly into the vacuum blood collection tubes. Using this bedside inactivation approach, we have developed a safe, rapid, and simplified bedside NA extraction method for the subsequent detection of a virus in lysis/binding buffer-inactivated whole blood. The NA extraction is directly performed in the blood collection tubes and requires no equipment or electricity. After the blood is collected into the lysis/binding buffer, the contents are mixed by flipping the tube by hand, and the mixture is incubated for 20 min at room temperature. Magnetic glass particles (MGPs) are added to the tube, and the contents are mixed by flipping the collection tube by hand. The MGPs are then collected on the side of the blood collection tube using a magnetic holder or a magnet and a rubber band. The MGPs are washed three times, and after the addition of elution buffer directly into the collection tube, the NAs are ready for NA tests, such as qPCR or isothermal loop amplification (LAMP), without the removal of the MGPs from the reaction. The NA extraction method is not dependent on any laboratory facilities and can easily be used anywhere (e.g., in field hospitals and hospital isolation wards). When this NA extraction method is combined with LAMP and a portable instrument, a diagnosis can be obtained within 40 min of the blood collection.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30010668      PMCID: PMC6102023          DOI: 10.3791/58001

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  15 in total

1.  Molecular Diagnostic Field Test for Point-of-Care Detection of Ebola Virus Directly From Blood.

Authors:  Jason W Benzine; Kerry M Brown; Krystle N Agans; Ronald Godiska; Chad E Mire; Krishne Gowda; Brandon Converse; Thomas W Geisbert; David A Mead; Yogesh Chander
Journal:  J Infect Dis       Date:  2016-09-16       Impact factor: 5.226

2.  Simple and Highly Sensitive Molecular Diagnosis of Zika Virus by Lateral Flow Assays.

Authors:  Dohwan Lee; Yong Shin; Seok Chung; Kyo Seon Hwang; Dae Sung Yoon; Jeong Hoon Lee
Journal:  Anal Chem       Date:  2016-11-23       Impact factor: 6.986

3.  Buffer AVL Alone Does Not Inactivate Ebola Virus in a Representative Clinical Sample Type.

Authors:  Sophie J Smither; Simon A Weller; Amanda Phelps; Lin Eastaugh; Sarah Ngugi; Lyn M O'Brien; Jackie Steward; Steve G Lonsdale; Mark S Lever
Journal:  J Clin Microbiol       Date:  2015-07-15       Impact factor: 5.948

4.  Monitoring of clinical and laboratory data in two cases of imported Lassa fever.

Authors:  Herbert Schmitz; Bernhard Köhler; Thomas Laue; Christian Drosten; Peter J Veldkamp; Stephan Günther; Petra Emmerich; Hans P Geisen; Klaus Fleischer; Matthias F C Beersma; Achim Hoerauf
Journal:  Microbes Infect       Date:  2002-01       Impact factor: 2.700

5.  Continuous-flow, microfluidic, qRT-PCR system for RNA virus detection.

Authors:  B Leticia Fernández-Carballo; Christine McBeth; Ian McGuiness; Maxim Kalashnikov; Christoph Baum; Salvador Borrós; Andre Sharon; Alexis F Sauer-Budge
Journal:  Anal Bioanal Chem       Date:  2017-11-07       Impact factor: 4.142

6.  Rapid Bedside Inactivation of Ebola Virus for Safe Nucleic Acid Tests.

Authors:  Maiken Worsøe Rosenstierne; Helen Karlberg; Karoline Bragstad; Gunnel Lindegren; Malin Lundahl Stoltz; Cristiano Salata; Anne-Marte Bakken Kran; Susanne Gjeruldsen Dudman; Ali Mirazimi; Anders Fomsgaard
Journal:  J Clin Microbiol       Date:  2016-07-27       Impact factor: 5.948

7.  A Portable, Pressure Driven, Room Temperature Nucleic Acid Extraction and Storage System for Point of Care Molecular Diagnostics.

Authors:  Samantha Byrnes; Andy Fan; Jacob Trueb; Francis Jareczek; Mark Mazzochette; Andre Sharon; Alexis F Sauer-Budge; Catherine M Klapperich
Journal:  Anal Methods       Date:  2013-07-07       Impact factor: 2.896

8.  Evaluation of the Biofire FilmArray BioThreat-E Test (v2.5) for Rapid Identification of Ebola Virus Disease in Heat-Treated Blood Samples Obtained in Sierra Leone and the United Kingdom.

Authors:  Simon A Weller; Daniel Bailey; Steven Matthews; Sarah Lumley; Angela Sweed; Derren Ready; Gary Eltringham; Jade Richards; Richard Vipond; Roman Lukaszewski; Phillippa M Payne; Emma Aarons; Andrew J Simpson; Emma J Hutley; Tim Brooks
Journal:  J Clin Microbiol       Date:  2015-11-04       Impact factor: 5.948

9.  Ebola viral load at diagnosis associates with patient outcome and outbreak evolution.

Authors:  Marc-Antoine de La Vega; Grazia Caleo; Jonathan Audet; Xiangguo Qiu; Robert A Kozak; James I Brooks; Steven Kern; Anja Wolz; Armand Sprecher; Jane Greig; Kamalini Lokuge; David K Kargbo; Brima Kargbo; Antonino Di Caro; Allen Grolla; Darwyn Kobasa; James E Strong; Giuseppe Ippolito; Michel Van Herp; Gary P Kobinger
Journal:  J Clin Invest       Date:  2015-11-09       Impact factor: 14.808

10.  Development and Evaluation of a Rapid and Sensitive EBOV-RPA Test for Rapid Diagnosis of Ebola Virus Disease.

Authors:  Mingjuan Yang; Yuehua Ke; Xuesong Wang; Hang Ren; Wei Liu; Huijun Lu; Wenyi Zhang; Shiwei Liu; Guohui Chang; Shuguang Tian; Lihua Wang; Liuyu Huang; Chao Liu; Ruifu Yang; Zeliang Chen
Journal:  Sci Rep       Date:  2016-06-01       Impact factor: 4.379

View more
  1 in total

1.  Rapid Nucleic Acid Extraction for Aquatic Animal DNA Virus Determination Using Chelex 100 Resin via Conventional PCR and Digital Droplet PCR Detection.

Authors:  Xi Hu; Nan Jiang; Yiqun Li; Yong Zhou; Yuding Fan; Mingyang Xue; Lingbing Zeng; Wenzhi Liu; Yan Meng
Journal:  Animals (Basel)       Date:  2022-08-08       Impact factor: 3.231

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.